2-(4-tert-Butylphenyl)-5-[4-(5,5-diethoxy-1,3-pentadiyn-1-yl)-
phenyl]-1,3,4-oxadiazole 4. Following the method used to
prepare 3, compound 213 (1.0 g, 3.1 mmol), ZnI2 (105 mg,
0.31 mmol), THF (10 cm3) and triethyl orthoformate (30 cm3)
were stirred under Ar for 3 h (oil-bath temperature 110 ЊC).
Chromatography (silica, DCM–diethyl ether 92 : 8, v/v) and
recrystallisation from ethanol–ethyl acetate gave 4 as white
needles (1.0 g, 77%) mp: 141–143 ЊC. δH (CDCl3): 1.28 (t,
J = 7.2 Hz, 6H), 1.38 (s, 9H), 3.66 (m, 2H), 3.78 (m, 2H), 5.41 (s,
1H), 7.56 (d, J = 8.0 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 8.06 (d,
J = 8.0 Hz, 2H), 8.11 (d, J = 8.0 Hz, 2H); δC (CDCl3): 15.3, 31.3,
35.4, 61.6, 69.7, 75.7, 78.3, 79.1, 91.8, 121.1, 124.7, 124.8, 126.4,
127.0, 127.1, 133.5, 155.9, 163.9, 165.2; MS (EI): m/z (%): 428
(Mϩ, 88), 383 (98), 355 (100). UV/Vis (DCM): λmax 324 nm.
Anal for C27H28N2O3 (428.21): calcd C, 75.68; H, 6.59; N, 6.54.
Found: C, 75.66; H, 6.57; N, 6.57%.
{3-[5-(4-tert-Butylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}-
propynal 5. Method (a). Compound 3 (1.0 g, 2.5 mmol) was
dissolved in acetone (100 cm3). Amberlyst-15 resin (1.0 g) and
water (1 cm3) were added and the mixture was stirred vigorously
for 36 h at 20 ЊC. The precipitate was removed by suction
filtration and washed with DCM. The filtrate was evaporated
in vacuo to yield a residue which was chromatographed (silica,
DCM–diethyl ether 94 : 6, v/v) and recrystallised from hexane–
ethyl acetate to yield 5 as white needles (0.80 g, 97%) mp: 152–
155 ЊC (decomp.). δH (CDCl3): 1.38 (s, 9H), 7.57 (d, J = 8.8 Hz,
2H), 7.78 (d, J = 8.8 Hz, 2H), 8.08 (d, J = 8.8 Hz, 2H), 8.20 (d,
J = 8.8 Hz, 2H), 9.47 (s, 1H); δC (CDCl3): 31.3, 35.6, 90.0, 93.4,
120.9, 122.7, 126.4, 127.1, 127.2, 134.0, 156.0, 163.6, 165.4,
176.7; MS (EI): m/z (%): 330 (Mϩ, 67), 315 (100). UV/Vis
(DCM): λmax 316 nm. Anal for C21H18N2O2 (330.14): calcd C,
76.34; H, 5.49; N, 8.48. Found: C, 76.32; H, 5.47; N, 8.50%.
Method (b). A solution of 3 (1.0 g, 2.5 mmol) in a mixture of
chloroform (60 cm3) and pure formic acid (30 cm3) was stirred
under Ar for 1 h at 10 ЊC and then stored for 24 h at 6–8 ЊC.
Water was added and the organic phase was washed with water
again several times (3 × 100 cm3), dried (MgSO4) and concen-
trated in vacuo. The residue was purified by chromatography
(silica, DCM–diethyl ether 95 : 5, v/v) to yield 5 (0.47 g, 57%)
identical with the sample above.
Fig. 1 X-Ray structures of 3, 4, 5 and 11, showing 50% atomic
displacement ellipsoids.
Table 1 Bond distances (Å)
3
4
5
11
C(24)–C(7)
C(7)–C(8)
C(8)–C(9)
C(9)–C(10)
C(10)–C(27)
C(9)–O(2)
C(9)–O(3)
1.441(2)
1.193(2)
1.478(2)
—
—
1.408(2)
1.406(2)
1.432(2)
1.200(2)
1.375(2)
1.201(2)
1.476(2)
1.393(2)a
1.420(3)a
1.430(2)
1.206(3)
1.445(3)
—
—
1.192(3)
—
1.433(2)
1.204(2)
1.419(2)
1.357(2)
1.357(2)
—
—
a Bonds C(27)–O(2) and C(27)–O(3).
decomplexation reactions occur smoothly to regenerate the
corresponding alkyne or diyne systems. X-Ray crystal struc-
ture analyses reveal that the π-systems of compounds 3, 4, 5
and 11 adopt predominantly planar conformations. Further
uses of the novel alkynes 1 and 2 as building blocks for the
synthesis of extended π-electron systems for advanced materials
applications are underway in our laboratory.13b
5-{4-[5-(4-tert-Butylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}-
penta-2,4-diynal 6. By analogy with the preparation of 5, com-
pound 9 (0.6 g, 1.4 mmol), acetone (100 cm3), Amberlyst-15
resin (1 g) and water (1 cm3) followed by chromatography
(silica, DCM–diethyl ether 92 : 8, v/v) gave 6 as a pale yellow
solid (0.5 g, 95%) mp: 127–130 ЊC (decomp.). δH (CDCl3): 1.38
(s, 9H), 7.66 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 8.07
(d, J = 8.4 Hz, 2H), 8.16 (d, J = 8.4 Hz, 2H), 9.31 (s, 1H);
δC (CDCl3): 31.3, 35.4, 83.8, 84.5, 87.6, 120.9, 123.2, 126.4,
127.1, 127.2, 132.8, 133.4, 155.9, 156.0, 163.8, 165.4, 175.8; MS
(EI): m/z (%): 354 (Mϩ, 26), 190 (98), 105 (100). UV/Vis
(DCM): λmax 333 nm. Anal for C23H18N2O (354.14): calcd C,
77.95; H, 5.12; N, 7.90. Found: C, 78.00; H, 5.14; N, 7.89%.
Experimental
General
The details are the same as those reported recently.3b
2-(4-tert-Butylphenyl)-5-[4-(3,3-diethoxypropyn-1-yl)phenyl]-
1,3,4-oxadiazole 3. Compound 113 (1.0 g, 3.3 mmol) and ZnI2
(100 mg, 0.33 mmol) were dissolved in triethyl orthoformate (30
cm3). The mixture was stirred under Ar for 5 h (oil-bath tem-
perature 140 ЊC) then cooled to 20 ЊC. The solvent was removed
in vacuo and the residue was chromatographed (silica, DCM–
diethyl ether 94 : 6, v/v) and recrystallised from ethanol–ethyl
acetate to obtain 3 as white needles (1.2 g, 85%) mp: 82–84 ЊC.
δH (CDCl3): 1.30 (t, J = 7.2 Hz, 6H), 1.38 (s, 9H), 3.70 (m, 2H),
3.85 (m, 2H), 5.53 (s, 1H), 7.56 (d, J = 8.0 Hz, 2H), 7.64 (d, J =
8.0 Hz, 2H), 8.06 (d, J = 8.0 Hz, 2H), 8.10 (d, J = 8.0 Hz, 2H); δC
(CDCl3): 15.4, 31.4, 35.4, 61.3, 84.5, 87.4, 91.9, 121.1, 124.3,
125.4, 126.3, 126.9, 127.1, 132.8, 155.8, 164.0, 165.1; MS (EI):
m/z (%): 404 (Mϩ, 52), 359 (100). UV/Vis (DCM): λmax 305 nm.
Anal for C25H28N2O3 (404.21): calcd C, 74.23; H, 6.98; N, 6.93.
Found: C, 74.19; H, 6.95; N, 6.97%.
2-(3-{4-[5-(4-tert-Butylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}-
prop-2-ynylidene)-1,3-dithiole-4,5-dimethyl dicarboxylate 11.
To a stirred solution of salt 722(1.2 g, 2.3 mmol) in dry THF
(20 cm3) under N2 at Ϫ78 ЊC, was added n-butyllithium (1.6 M
solution in hexane, 1.5 cm3, 2.4 mmol). The reaction mixture
was stirred for 30 min, then a solution of 5 (0.8 g, 2.3 mmol) in
THF (30 cm3), was added very slowly and the mixture was
left to warm to room temperature with stirring overnight. The
solvents were removed in vacuo and the residue was chromato-
graphed (silica, DCM–diethyl ether 96 : 4, v/v) and recrystal-
lised from hexane–ethyl acetate to yield 11 as yellow–orange
needles (0.40 g, 33%) mp: 201–20 ЊC. δH (CDCl3): 1.38 (s, 9H),
3.86 (s, 3H), 3.88 (s, 3H), 5.65 (s, 1H), 7.56 (d, J = 8.5 Hz,
2H), 7.58 (d, J = 8.5 Hz, 2H), 8.06 (d, J = 8.5 Hz, 2H), 8.08
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 8 5 8 – 8 6 2
860